RAC 0.91% $1.64 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-313

  1. 1,251 Posts.
    lightbulb Created with Sketch. 12370
    $1.5B in sales (3,750,000 cycles of dox per year)

    10% market capture

    375,000 cycles of dox per year

    $20,000 per cycle of Bis

    $7.5B/annum @ 10% market capture
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.